XML 18 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance at Dec. 31, 2019 $ 698,426 $ (1,066) $ 12 $ 1,012,218 $ 29 $ (313,833) $ (1,066)
Balance, Shares at Dec. 31, 2019     119,897        
Vesting of early exercised stock options 26     26      
Issuance of common stock pursuant to equity incentive plans 5,877     5,877      
Issuance of common stock pursuant to equity incentive plans, Shares     1,683        
Issuance of common stock in connection with at-the-market offering, net of issuance costs 349,609     349,609      
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs, Shares     3,004        
Stock-based compensation expense $ 60,441     60,441      
Accounting Standards Update Extensible List us-gaap:AccountingStandardsUpdate201613Member            
Net income (loss) $ (97,760)         (97,760)  
Balance at Jun. 30, 2020 1,015,553   $ 12 1,428,171 29 (412,659)  
Balance, Shares at Jun. 30, 2020     124,584        
Balance at Mar. 31, 2020 675,913   $ 12 1,045,383 29 (369,511)  
Balance, Shares at Mar. 31, 2020     120,657        
Vesting of early exercised stock options 9     9      
Issuance of common stock pursuant to equity incentive plans 3,134     3,134      
Issuance of common stock pursuant to equity incentive plans, Shares     923        
Issuance of common stock in connection with at-the-market offering, net of issuance costs 349,609     349,609      
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs, Shares     3,004        
Stock-based compensation expense 30,036     30,036      
Net income (loss) (43,148)         (43,148)  
Balance at Jun. 30, 2020 1,015,553   $ 12 1,428,171 29 (412,659)  
Balance, Shares at Jun. 30, 2020     124,584        
Balance at Dec. 31, 2020 1,328,015   $ 13 1,660,379 29 (332,406)  
Balance, Shares at Dec. 31, 2020     128,004        
Vesting of early exercised stock options 4     4      
Issuance of common stock pursuant to equity incentive plans 10,285     10,285      
Issuance of common stock pursuant to equity incentive plans, Shares     2,658        
Issuance of common stock in connection with at-the-market offering, net of issuance costs 989,615     989,615      
Issuance of common stock pursuant in connection with at-the-market offerings, net of issuance costs, Shares     2,637        
Stock-based compensation expense 83,346     83,346      
Net income (loss) 149,763         149,763  
Balance at Jun. 30, 2021 2,561,028   $ 13 2,743,629 29 (182,643)  
Balance, Shares at Jun. 30, 2021     133,299        
Balance at Mar. 31, 2021 2,441,312   $ 13 2,697,380 29 (256,110)  
Balance, Shares at Mar. 31, 2021     132,304        
Issuance of common stock pursuant to equity incentive plans 3,580     3,580      
Issuance of common stock pursuant to equity incentive plans, Shares     995        
Stock-based compensation expense 42,669     42,669      
Net income (loss) 73,467         73,467  
Balance at Jun. 30, 2021 $ 2,561,028   $ 13 $ 2,743,629 $ 29 $ (182,643)  
Balance, Shares at Jun. 30, 2021     133,299